Latest papers

Case Management Intervention in Cervical Cancer Prevention: The Boston REACH Coalition Women's Health Demonstration Project.

Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India.

Factors related to elevated vaginal pH in the first trimester of pregnancy.

[New guidelines for prevention of cervix cancer. ARG report on investigation and treatment of abnormal cytological smears].

Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?

Stage IIIB carcinoma of the cervix in a 19-year-old: a case report.

Prevalence of human papillomavirus infection in women in Benin, West Africa.

Cervical cytology biobanks as a resource for molecular epidemiology.

Cervical insulin-like growth factor binding protein-1 (IGFBP-1) to predict spontaneous onset of labor and induction to delivery interval in post-term pregnancy.

To treat or not to treat; the clinical dilemma of atypical squamous cells of undetermined significance (ASC-US).

Evaluation of women knowledge and attitude regarding cervical cancer early detection.

Frequency of human papillomavirus infection and genotype distribution among women with known cytological diagnosis in a Southern Italian region.

Knowledge of cervical cancer, pap testing and the human papillomavirus among young Australian women.

Colposcopy prediction of progression in human papillomavirus infections with minor cervical lesions.

Access versus acculturation: identifying modifiable factors to promote cancer screening among Asian American women.

Cervical cancer in lesbians. A call to action.

Common abnormal results of pap and human papillomavirus cotesting: what physicians are recommending for management.

2009 cervical cytology guidelines and chlamydia testing among sexually active young women.

A comparison of health care in Canada and the United States: the case of Pap smears.

[Economic aspects of using selected biomarkers in cervical cancer screening].